Myths, misconceptions and mixed cryoglobulinemia associated with HCV infection

Minerva Gastroenterologica e Dietologica

Volumn 48, Issue 4, 2002, Pages 319-329

  De Rosa, F G ^a   Pucillo, L P ^b   Casato, M ^c   Agnello, V ^d,e  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Cryoglobulinemia, diagnosis; Cryoglobulinemia, therapy; Hepatitis C

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CRYOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; RHEUMATOID FACTOR;

ANTIBODY PRODUCTION; AUTOIMMUNITY; B CELL LYMPHOMA; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CLONAL VARIATION; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC LINE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN GENE; LIVER CIRRHOSIS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NONHODGKIN LYMPHOMA; PREVALENCE; REVIEW; TREATMENT OUTCOME;

EID: 0036931550     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia: a clinical and laboratory study. Am J Med 1966;40:837-56.
2. Agnello V. Mixed cryoglobulinemia and other extrahepatic manifestations of HCV infection. In: Liang TJ, Hoofnagle JH, editors. Hepatitis C. San Diego: Academic Press, 2000.p.295-313.
3. Lunel F, Musset L. Mixed cryoglobulinemia and hepatitis C virus infection. Minerva Med 2001;92:35-42.
4. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinemias. Q J Med 1995;88:115-26.
5. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974;57:775-88.
6. Kayali Z, Buckwold VE, Dimmerman B, Schmidt WN. Increased cirrhosis in patients with cryoglobulinemia and hepatitis C: a meta-analysis. Hepatitis Single Topic Conference: Co-Morbid Conditions Associated with Hepatits C. 2002 April; AASLD, Chicago, II: Abstract Book; 2002.p.136.
7. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-300.
8. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997; 19:111-29.
9. Fornasieri A, D'Amico G. Type II mixed cryoglobulinemia, hepatitis C infection, and glomerulonephritis. Nephrol Dial Transplant 1996;11 Suppl 4:25-30.
10. Musset L, Diemert MC, Taibi F, Thei Huong Du L, Cacoub P, Leger JM et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
11. Schifferli JA, Rrench LE, Tissot J-D. Hepatitis C virus infection, cryoglobulinemia, and glomerulonephritis. Adv Nephrol 1995;24:107-29.
12. Gao L, Knight GB, Agnello V. Molecular analysis of clonal B cell expansion in HCV infection: a potential marker for development type-2 mixed cryoglobulinemia. Antiviral Ther 2000;5 Suppl:C42.
13. Gao L, Knight GB, Agnello V, unpublished data.
14. Strassburg CP, Obermayer-Straub P, Manns MP. Auatoimmunity in hepatits C and D virus infection. J Viral Hepatitis 1996;3:49-59.
15. Muratori L, Gibellini D, Lenzi Cataleta M, Muratori P, Morelli MC et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 1996;248:164-71.
16. Laskus T, Radkowski M, Wang L, Snook JL, Vargas H, Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1. Correlation with extrahepatic viral replication. Virology 1998;248:164-71.
17. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX, Liu F. The low density lipoprotein receptor is a receptor for Flavivirdae members: hepatitis C, hepatitis G and bovine viral diarrhea virus. Proc Nat Acad Sci 1999;96:127-66.
18. De Vita S, Sasonno D, Dolcetti R, Ferraccioli G, Carbone A, Cornacchiulo V et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:1887-92.
19. Ascoli V, Lo Coco F, Artini M, Levrero M, Martelli M, Negro F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998;109:600-9.
20. rd Int. Meeting Hepatitisand Related Virus; Gold Coast, Australia; 1995.
21. Haddad J, Deny P, Munz-Gotheil CM, Ambrosini JC, Trinchet JC, Pateron D et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
22. Kioke K, Moriya K, Ishibashi K, Votsuyanagi H, Shiutani Y, Fujre H et al. Sialadenitis histologic resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997;94:233-6.
23. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblast to tumorgenic penotype. J Virol 1996;70:4438-43.
24. Zignego AL, Giannelli F, Marocchi E, Mazzocca A, Ferri C, Giannini C et al. T(14; 18) translocation in chronic hepatitis C virus infection. Hepatology 2000;31:474-9.
25. Casato M, Meccucci C, Agnello V, Fiorilli M, Knight GB, Matteucci C et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002;99:2259-61.
26. Kitay-Cohen Y, Amiel A, Hilzenrat N, Buskila D, Ashur Y, Fejgin M et al. Bcl-2 rearrangement in patients with chronic hepatits C associted with essential mixed cryoglobulinemia type II. Blood 2000;96:2910-12.
27. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E et al. Bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001;112:364-9.
28. Sasso E, Martinez M, Ghillani P, Musset L, Halfon P, Piette JC et al. Increased prevalence of translocation of bcl-2 to the IgJ H locus t(14;18) in patients with hepatitis C-associated type II mixed cryolobulins [abstract]. Arth Rheum 2000;43:744.
29. th International Symposium on Viral Hepatitis and Liver Disease, 2000 April; Atlanta, Georgia.
30. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001;97:1555-9.
31. LkV325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998;91:2433-42.
32. Mazzaro C, Franzin F, Tulissi P, Pussini E, Crovatto M, Carniello GS et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to α-interferon therapy. Cancer 1996;77:2604-13.
33. Dierlamm J, Wlodarska I, Stefanova M, Hinz K, Van den Berghe H, Hagemeijer A et al. Genetic abnormalities in marginal zone B-cell lymphoma. Hematol Oncol 2000;18:1-13.
34. Monteverde A, Ballare M, Plier S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997;19:99-110.
35. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
36. Knight GB, Agnello V. WA monoclonal RF and non-Hodkin's lymphoma. Blood 2001;197:3319-20.
37. De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000;96:3578-84.
38. Quinn ER, Chan CH, Hadlock KG, Foung SKH, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001;98:3745-9.
39. Chen PP, Fong S, Normansell D, Houghten RA, Karras JG, Vaughan JH et al. Delineation of a crossreactive idiotype on human autoantibodies with antibody against a synthetic peptide. J Exp Med 1984;159:1502-11.
40. Agnello V, Goni F, Barnes JL, De La Vega M-T, Frangione B. Human rheumatoid factor crossidiotypes II. Primary structure-dependent crossreactive idiotype, PSL2-CRI, present on WA monclonal rheumatioid factors is present on BLA and other IgMκ monoclonal autoantibodies. J Exp Med 1987;165:263-7.
41. Agnello V, Barnes JL. Human rheumatoid factor crossidiotypes: WA and BLA are heat-labile conformational antigens requiring both heavy and light chains. J Exp Med 1986;164:1809-14.
42. Knight GB, Agnello V, Bonagura V, Barnes L, Panka DJ, Zhang QX. Human rheumatoid factor cross-idiotypes IV. Studies on WA Xld-positive IgM without rheumatoid factor activity provide evidence that the WA Xld is not unique to rheumatoid factors and is distinct from the 17.109 and G6 Xlds. J Exp Med 1993;178:1903-11.
43. Cordonnier D, Martin H, Groslambert P, Micouin C, Chenais F, Stoebner P. Mixed IgG-IgM cryoglobulinemia with glimerulonephritis. Immunochemical florescent and ultrasructural study of kidney and in vitro cryoprecipitate. Am J Med 1975;59:867-72.
44. Stoebner P, Renversez JC, Groulde J, Vialtel P, Cordonnier D. Ultrastructural study for human IgG and IgG-IgM crystalcryoblobulins. Am J Clin Pathol 1978;4:404-10.
45. Pucillo LP, Agnello V. Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from viruslike particles in the cryoprecipitate to viral localization in parameesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994;3:465-70.
46. Agnello V, Koffler D, Kunkel HG. Studies on the different immune complex systems in the nephritis of systemic lupus erythematosus. Kidney Int 1973;3:90-9.
47. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
48. Johnson RJ, Gretch DR, Couser WG, Alpers CE, Wilson J, Chung M et al. Hepatitis C virus-associated glomerulonephritis. Effect of α-interferon therapy. Kidney Int 1994;46:1700-74.
49. Rostoker G, Deforges L, Ben Maadi A, Remy P, Bourgeon B, Lang P et al. Low prevalence of hepatitis C virus antibodies among adult patients with primary glomerulonephritis in France. Nephron 1993;63:367.
50. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kid Dis 1995;25:361-9.
51. Mac-Moune Lai F, Tam JSL, Liew CT, Ip M, Lai KN. Low prevalence of hepatits C virus antibodies with primary membranous nephropathy and membranoproliferative glomerulonephritis in Hong Kong. Nephron 1995;70: 367-8.
52. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M et al. Hepatitis C vius infection and membranoproliferative glomerulonephritis in Japan. J M Soc Neprhrol 1995;6:220-3.
53. Cosio FG, Roche S, Agarwal A, Falkenhain ME, Sedmak DD, Fergurson RM. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kid Dis 1996;28:752-8.
54. Stehman-Breen C, Willson R, Johnson RJ. Is there a hepatitis C virus-associated membranoprolferative glomerulonephritis? Am J Kidney Dis 1997;30:589-90.
55. Maggiore Q, Bartolomeo F, L'Abbate A, Misefari V. HBsAg glomerular deposit in glomerulonephritis: fact or artifact? Kidney Int 1981;19:579-86.
56. National Institutes of Health Continuing Medical Education. Management of hepatitis C. NIH Consensus Statement 1997;15:1-41.
57. Appel GB. Personal communication.
58. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I et al. Glomerulonephritis in autopsy cases with hepatits C virus infection. Intern Med 1998;37:836-40.
59. Agnello V. Mixed cryoglobulinemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis 1998;57:701-2.
60. Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997;90:3865-73.
61. Agnello V. Therapy for cryoglobulinemia secondary to hepatitis C virus: the need for tailored protocols and multiclinic studies. J Rheumatol 2000;27:2065-7.
62. Liu F, Knight GB, Agnello V. Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia. Arthritis Rheum 1999;42:1898-901.
63. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998;160:3594-601.
64. Monteverde A, Ballare M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997;19:99-110.